Literature DB >> 10401470

Treating visual hallucinations with donepezil.

W J Burke, W H Roccaforte, S P Wengel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10401470     DOI： 10.1176/ajp.156.7.1117a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

Review 1.  Visual hallucinations and the Charles Bonnet syndrome.

Authors:  Dominic H Ffytche
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

Review 2.  Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents.

Authors:  T Burt
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

3.  Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.

Authors:  Tsutomu Furuse; Kenji Hashimoto
Journal:  Ann Gen Psychiatry       Date:  2010-04-24       Impact factor: 3.455

Review 4.  Brain modules of hallucination: an analysis of multiple patients with brain lesions.

Authors:  Claude M J Braun; Mathieu Dumont; Julie Duval; Isabelle Hamel-Hébert; Lucie Godbout
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

5.  Withdrawal syndrome after donepezil cessation in a patient with dementia.

Authors:  Leszek Bidzan; Mariola Bidzan
Journal:  Neurol Sci       Date:  2012-01-15       Impact factor: 3.307

6.  Visual hallucinatory syndromes: past, present, and future.

Authors:  Dominic H Ffytche
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 7.  Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.

Authors:  John O'Brien; John Paul Taylor; Clive Ballard; Roger A Barker; Clare Bradley; Alistair Burns; Daniel Collerton; Sonali Dave; Rob Dudley; Paul Francis; Andrea Gibbons; Kate Harris; Vanessa Lawrence; Iracema Leroi; Ian McKeith; Michel Michaelides; Chaitali Naik; Claire O'Callaghan; Kirsty Olsen; Marco Onofrj; Rebecca Pinto; Gregor Russell; Peter Swann; Alan Thomas; Prabitha Urwyler; Rimona Sharon Weil; Dominic Ffytche
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-25       Impact factor: 10.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.